Holen Sie sich die Stockscreener-App
336.34
0.26%
-0.86
Handel nachbörslich:
336.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$337.20
Offen:
$340
24-Stunden-Volumen:
528.67K
Relative Volume:
0.92
Marktkapitalisierung:
$24.40B
Einnahmen:
$2.88B
Nettoeinkommen (Verlust:
$499.60M
KGV:
49.90
EPS:
6.74
Netto-Cashflow:
$321.60M
1W Leistung:
+1.39%
1M Leistung:
+0.62%
6M Leistung:
+2.84%
1J Leistung:
-0.93%
1-Tages-Spanne:
$335.15
$340.97
1-Wochen-Bereich:
$321.46
$341.84
52-Wochen-Spanne:
$265.00
$413.70
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
336.34 | 24.40B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
592.64 | 211.09B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
237.38 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.37 | 41.73B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
239.78 | 35.23B | 4.81B | 1.11B | 1.35B | 7.55 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Artemis Investment Management LLP Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now - Yahoo Finance
Seilern Investment Management Ltd Buys Shares of 443,825 West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Annex Advisory Services LLC Has $15.94 Million Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
7,793 Shares in West Pharmaceutical Services, Inc. (NYSE:WST) Purchased by Avanza Fonder AB - MarketBeat
Park Avenue Securities LLC Has $2.86 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
(WST)Analyzing West Pharmaceutical Servs's Short Interest - Benzinga
Rockland Trust Co. Purchases 3,102 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
YieldBoost West Pharmaceutical Services To 6.3% Using Options - Nasdaq
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Bright Rock Capital Management LLC - MarketBeat
West Pharmaceutical Services to Present at CJS Annual Virtual Investor Conference - MSN
Deerfield Group Expands Focus on West Coast Biotech and Pharmaceutical Markets - MyChesCo
West Pharmaceutical Services started at buy by Citi - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Citigroup Initiates Coverage of West Pharmaceutical Services (WST) with Buy Recommendation - MSN
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (NYSE:WST) Now Covered by Citigroup - MarketBeat
West Pharmaceuticals: Cannot Wrap My Head Around Valuations (Rating Downgrade) (NYSE:WST) - Seeking Alpha
U.S. Pharmaceutical Packaging Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
WSTWest Pharmaceutical Services, Inc. Latest Stock News & Market Updates - StockTitan
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference - The Malaysian Reserve
West Pharmaceutical to Present at CJS Annual New Ideas Conference in January 2025 - StockTitan
West Pharmaceutical Services, Inc. (NYSE:WST) is Dudley & Shanley Inc.'s 9th Largest Position - MarketBeat
West Pharmaceutical Services (NYSE:WST) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference - The Eastern Progress Online
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by Principal Financial Group Inc. - MarketBeat
West Pharmaceutical Services Inc. stock rises Tuesday, still underperforms market - MarketWatch
Dudley & Shanley Inc. Has $24.35 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Is It Too Late To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)? - Yahoo Finance
West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Not Quite Adding Up - Simply Wall St
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks? - MSN
Top 10 Companies in Pre Filled Syringe [2025] - Verified Market Reports
Looking Into West Pharmaceutical Servs's Recent Short Interest - Benzinga
Janet Haugen Joins West Pharmaceutical Services Board of Directors - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stake Lifted by Sanctuary Advisors LLC - MarketBeat
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Orion Portfolio Solutions LLC Sells 4,029 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by XTX Topco Ltd - MarketBeat
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.34%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):